期刊文献+

以尿钙排泄量为效应指标评价枸橼酸氢钾钠颗粒人体生物等效性 被引量:1

Evaluation of the bioequivalence of domestic and imported Potassium Sodium Hydrogen Citrate Granules with accumulative urinary excretion of calcium as index in healthy volunteers
下载PDF
导出
摘要 目的以24h尿液钙离子累计排泄量为指标,比较国产和进口枸橼酸氢钾钠颗粒剂的生物等效性。方法36名男性健康志愿者按自身交叉设计,随机口服枸橼酸氢钾钠颗粒剂的受试制剂(国产)或参比制剂(进口)5.0g,(洗脱期7d)。分别收集给药前(空白)和给药后0~2、2~4、4~6、6~8、8~10,10-2、12~24h的尿液,记录尿量,采用原子吸收分光光度法测定尿液钙离子浓度,计算给药前、后24h尿液钙累积排泄量。结果受试制剂给药前、后24h尿钙累积排泄量为(128.47±76.45)mg和(163.53±81.28)mg;参比制剂给药前、后24h尿钙累积排泄量为(128.34±59.55)mg和(179.65±103.96)mg。给予受试制剂和参比制剂后24h尿钙排泄量分剐比用药前增加(35.06±61.26)mg和(51.31±73.18)mg,两制剂间没有显著性差异(P〉0.05)。结论国产和进口枸橼酸氢钾钠颗粒剂具有生物等效性,尿液钙离子累计排泄量可用于国产和进口构橼酸氢钾钠颗粒剂生物等效性评价。 Objective To evaluate the bioequivalence of imported and domestic Potassium Sodium Hydrogen Citrate Granules with accumulative urinary excretion of calcium as index in Chinese healthy volunteers. Methods Thirty - six healthy male volunteers were randomLy administered with a oral single dose of 5.0 g domestic (test) and imported ( refer- ence) Potassium Sodium Hydrogen Citrate Granules in a crossover study with a washout period of 7 days. Urine was collect- ed before or after oral doses at the scheduled time (0 - 2,2 - 4,4 - 6,6 - 8,8 - 10, l0 - 12,12 - 24 h ) . Urine volumes were recorded,urinary calcium concentration was determined by atomic absorption spectrophotometric and twenty - four hours of accumulative urinary excretion of calcium were calculated. Results Twenty - four hours of accumulative urinary excretion of calcium were ( 128.47± 76.45 )mg and ( 163.53 ± 81.28 } mg before and after taking test preparation ; ( 128.34 ±59.55 )mg and ( 179.65 ±103.96 )mg before and after taking reference preparation, respectively. Increase in 24 h urinary excretion of calcium after taking test and reference preparation were ( 35.06 ± 61.26 ) mg and ( 51.31 ± 73.18 ) mg, respec- tively. There was no significant difference( P 〉 0.05 ) in increase of 24 h accumulative urinary excretion of calcium between the two preparations. Conclusion The domestic and imported Potassium Sodium Hydrogen Citrate Granules were bioequiv- alent.
出处 《药学研究》 CAS 2014年第9期501-504,共4页 Journal of Pharmaceutical Research
关键词 枸橼酸氢钾钠颗粒 参比制剂 受试制剂 生物等效性 原子吸收分光光度法 Potassium Sodium Hydrogen Citrate Granules Reference preparation Test preparation Calcium Bioequiv-alence Atomic absorption spectrophotometry
  • 相关文献

参考文献7

二级参考文献55

  • 1孙西钊.枸橼酸氢钾钠防治尿石症研究进展[J].中华实验外科杂志,2005,22(9):1148-1149. 被引量:29
  • 2陈志强,王超,余九虎,姚林方,杨为民,叶章群.血生化分析仪定量测定尿液中钙、磷、尿酸的实验研究[J].临床泌尿外科杂志,2006,21(6):461-463. 被引量:6
  • 3代海涛,陈志强,叶章群.枸橼酸氢钾钠降低草酸钙结石成石危险性的机制[J].临床泌尿外科杂志,2007,22(4):287-288. 被引量:12
  • 4化学药物制剂人体生物利用度和生物等效性研究技术指导原则[S].国家食品药品监督管理局,指导原则号:[H]GCL2-1.
  • 5Ekman M, Reizenstein P, Teigen SW, et al. Comparative absorption of Calcium from carbonate tablets, iactogluconate/ carbonate effervescent tablets, and chloride solution [J]. Bone, 1997, 12: 93-97.
  • 6Devine A, Wilson SG, Dick IM, et al. Effects of vitamin D metabolites on intestinal calcium absorption and bone turnover in elderly women[J]. Am J Clin Nutr, 2002, 75: 283-288.
  • 7Scopacasa F, Wishart JM, Horowitz M, et al. Relation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to ealcitriol[J]. Eur J Clin Nutr, 2004, 58:264 269.
  • 8Mattle D,Hess B.Preventive treatment of nephmlithiasis with alkali citrate-a critical review[J].Uml Res,2005,33(2):73-79.
  • 9Lee YH,Huang WC,Tsai JY,et al.The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi:a midterm follow-up study[J].J Urol,1999,161(5):1453-1457.
  • 10国家食品药品监督管理局.化学药物制剂人体生物利用度和生物等效性研究技术指导原则[M].北京:中国医药科技出版社,2005:145-160.

共引文献36

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部